Impact of dopamine-related genetic variants on physical activity in old age - a cohort study.


Journal

The international journal of behavioral nutrition and physical activity
ISSN: 1479-5868
Titre abrégé: Int J Behav Nutr Phys Act
Pays: England
ID NLM: 101217089

Informations de publication

Date de publication:
24 05 2020
Historique:
received: 22 10 2019
accepted: 11 05 2020
entrez: 26 5 2020
pubmed: 26 5 2020
medline: 20 11 2020
Statut: epublish

Résumé

The beneficial effects of a physically active lifestyle in aging are well documented. Understanding the factors of importance for physical activity in older adults are therefore essential. Informed by animal and human data linking the dopamine system to motivation and reward processes, we investigated the associations between variations in dopamine genes and objectively measured physical activity and sedentary behaviour. Further, we aimed to verify whether higher age may exacerbate the impact of dopamine genes on physical activity. We analyzed data from 504 older adults, 66-87 years, from the population-based Swedish National study on Aging and Care in Kungsholmen (SNAC-K). Physical activity was measured with activPAL accelerometers and DNA was extracted from blood samples for genotyping. We assessed the effects of three dopamine relevant genetic variations (DRD1, DRD2, and DRD3) on daily time in sedentary behavior, light-intensity physical activity and moderate-to-vigorous physical activity using analyses of covariance, adjusting for sex, age and physical function. Higher dopamine receptor efficacy was related to moderate-to-vigorous physical activity, but not to light-intensity physical activity or sedentary time. DRD1 explained 2.7% of variance in moderate-to-vigorous physical activity, with more pronounced effect in people aged ≥80 years, about 10% of explained variance. Stronger genetic effects in older adults are in line with the well-established nonlinear effects of dopamine signaling on performance, expected to be exacerbated with aging. Individuals over 80 years, genetically predisposed to lower dopamine receptor efficacy, engaged on average 100 min/week in moderate-to-high physical activity, below the recommended levels beneficial for healthy aging. Our findings highlight that some individuals might need extra support to maintain a physically active lifestyle.

Identifiants

pubmed: 32448293
doi: 10.1186/s12966-020-00971-2
pii: 10.1186/s12966-020-00971-2
pmc: PMC7245799
doi:

Substances chimiques

Receptors, Dopamine 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

68

Références

Eur Rev Aging Phys Act. 2019 Feb 18;16:3
pubmed: 30820261
Neuroscience. 2014 Dec 12;282:13-22
pubmed: 24463000
Neurosci Biobehav Rev. 2006;30(6):791-807
pubmed: 16901542
Neuroimage. 2018 Nov 1;181:605-616
pubmed: 30041059
Aging Clin Exp Res. 2004 Apr;16(2):158-68
pubmed: 15195992
Int J Behav Nutr Phys Act. 2012 Oct 04;9:122
pubmed: 23034100
J Neurosci. 2014 Apr 9;34(15):5335-41
pubmed: 24719111
Br J Sports Med. 2017 Nov;51(21):1539
pubmed: 28724714
J Gerontol. 1994 May;49(3):M97-108
pubmed: 8169338
J Am Geriatr Soc. 1997 Jun;45(6):735-8
pubmed: 9180669
Physiol Behav. 2003 Apr;78(4-5):751-7
pubmed: 12782232
Circulation. 2010 Aug 17;122(7):743-52
pubmed: 20713909
J Sci Med Sport. 2018 Jul;21(7):702-707
pubmed: 29128418
Br J Sports Med. 2018 Jun;52(12):776-788
pubmed: 29858465
Neuropsychopharmacology. 2016 May;41(6):1629-36
pubmed: 26503310
Hum Brain Mapp. 2015 Apr;36(4):1325-34
pubmed: 25486867
Prev Med. 2014 Dec;69:28-35
pubmed: 25193005
Neuroimage. 2019 Nov 15;202:116044
pubmed: 31352122
Lancet. 2012 Jul 21;380(9838):258-71
pubmed: 22818938
BMJ. 2019 Aug 21;366:l4570
pubmed: 31434697
Int J Epidemiol. 2012 Oct;41(5):1460-71
pubmed: 23045206
Curr Opin Psychiatry. 2015 Jan;28(1):7-12
pubmed: 25415499
J Am Geriatr Soc. 2018 Jul;66(6):1172-1179
pubmed: 29637543
Neuropsychobiology. 2006;53(1):46-50
pubmed: 16397404
Nat Commun. 2018 Mar 14;9(1):1086
pubmed: 29540712
Trends Cogn Sci. 2015 Sep;19(9):506-14
pubmed: 26187033
Biol Psychiatry. 2011 Jun 15;69(12):e113-25
pubmed: 21531388
Psychopharmacology (Berl). 2016 Feb;233(3):393-404
pubmed: 26554387
Annu Rev Neurosci. 2007;30:259-88
pubmed: 17600522
Biol Psychiatry. 2012 Oct 15;72(8):671-6
pubmed: 22683091
Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):873-9
pubmed: 18351593
Biol Psychiatry. 2016 Jun 1;79(11):887-97
pubmed: 26281715
Hum Genet. 2008 Mar;123(2):133-40
pubmed: 18092181
Cereb Cortex. 2020 Mar 14;30(3):989-1000
pubmed: 31504282
Biomed Res Int. 2014;2014:591717
pubmed: 24734235
Nat Commun. 2016 Jun 23;7:11829
pubmed: 27337658
Neurobiol Aging. 2018 Jun;66:180.e11-180.e21
pubmed: 29525179
Am J Epidemiol. 2008 Apr 1;167(7):875-81
pubmed: 18303006
Int J Behav Nutr Phys Act. 2011 Dec 28;8:142
pubmed: 22204444
Br J Sports Med. 2014 Jul;48(13):1019-23
pubmed: 24782483
PLoS One. 2017 Jun 29;12(6):e0180119
pubmed: 28662164
Sports Med. 1999 Dec;28(6):397-411
pubmed: 10623983
Addict Sci Clin Pract. 2011 Jul;6(1):4-16
pubmed: 22003417
J Phys Act Health. 2018 Dec 17;:1-11
pubmed: 30558473
J Pharmacol Exp Ther. 2002 Jun;301(3):1166-78
pubmed: 12023552
Synapse. 2009 Oct;63(10):907-12
pubmed: 19582781
Am J Prev Med. 2012 Mar;42(3):e3-28
pubmed: 22341176
Neurosci Biobehav Rev. 2010 Apr;34(5):721-33
pubmed: 19850077
Int J Environ Res Public Health. 2014 Jan 07;11(1):773-91
pubmed: 24402064
J Sport Health Sci. 2017 Jun;6(2):162-178
pubmed: 30356601
Physiol Meas. 2016 Sep 21;37(10):1653-1668
pubmed: 27652827
Prev Med. 2012 Jan;54(1):82-7
pubmed: 22057055
Am J Clin Nutr. 2012 Feb;95(2):437-45
pubmed: 22218159
Am J Clin Nutr. 2013 Nov;98(5):1317-25
pubmed: 24047914
Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10753-8
pubmed: 16809426

Auteurs

Ing-Mari Dohrn (IM)

Aging Research Center, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet and Stockholm University, Tomtebodavägen 18 A, Solna, SE-171 65, Sweden. ing-mari.dohrn@ki.se.

Goran Papenberg (G)

Aging Research Center, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet and Stockholm University, Tomtebodavägen 18 A, Solna, SE-171 65, Sweden.

Elisabeth Winkler (E)

School of Population Health, University of Queensland, Brisbane, Australia.
School of Public Health, University of Queensland, Herston, Australia.

Anna-Karin Welmer (AK)

Aging Research Center, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet and Stockholm University, Tomtebodavägen 18 A, Solna, SE-171 65, Sweden.
Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Stockholm, Sweden.
Allied Health Professionals, Function Area Occupational Therapy & Physiotherapy, Karolinska University Hospital, Stockholm, Sweden.
Stockholm Gerontology Research Center, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH